Similar companies
| Company | Est. Net Value | |
|---|---|---|
 |
AstrazenecaAZN |
$32,000 |
 |
Johnson & JohnsonJNJ |
-$400,000 |
 |
ModernaMRNA |
$16,000 |
 |
AbbVieABBV |
$72,000 |
 |
Eli Lilly and CompanyLLY |
-$100,000 |
Are Members of Congress Buying or Selling Pfizer?
No members of Congress have reported trading Pfizer (PFE) stock in the past 90 days. The history below covers the past two years.
Congressional trading is one of the alternative data signals AltIndex tracks as part of the PFE AI Score. For corporate insider activity, see PFE insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.
Which Congress Members Are Trading Pfizer?
| Member of Congress | Activity | Trades | Last Trade |
|---|---|---|---|
| James French Hill | Sold $180,000 | 1 | Dec 31, 2025 |
| Rob Bresnahan | Bought $66,000 | 3 | May 15, 2025 |
| Gil Cisneros | Sold $41,000 | 4 | Apr 29, 2025 |
| Laurel Lee | Bought $33,000 | 1 | Oct 21, 2024 |
| Jefferson Shreve | Bought $33,000 | 1 | Feb 24, 2025 |
| Tommy Tuberville | Sold $33,000 | 1 | Jun 8, 2026 |
PFE Congressional Trade History
| Member of Congress | Trade Date | Type | Estimated Size |
|---|---|---|---|
| Ro Khanna | Jul 7, 2026 | Buy | $1K – $15K |
| Tommy Tuberville | Jun 8, 2026 | Sell | $15K – $50K |
| Gilbert Cisneros | Feb 10, 2026 | Buy | $1K – $15K |
| James French Hill | Dec 31, 2025 | Sell | $100K – $250K |
| Gilbert Cisneros | Dec 19, 2025 | Sell | $1K – $15K |
| Lisa McClain | Jul 16, 2025 | Buy | $1K – $15K |
| Josh Gottheimer | Jun 3, 2025 | Sell | $1K – $15K |
| Gilbert Cisneros | May 30, 2025 | Buy | $1K – $15K |
| Rob Bresnahan | May 15, 2025 | Buy | $15K – $50K |
| Gil Cisneros | Apr 29, 2025 | Buy | $1K – $15K |
| Bruce Westerman | Apr 21, 2025 | Sell | $1K – $15K |
| Rob Bresnahan | Apr 8, 2025 | Sell | $15K – $50K |
| Gil Cisneros | Mar 31, 2025 | Sell | $15K – $50K |
| Bruce Westerman | Mar 3, 2025 | Buy | $1K – $15K |
| Gil Cisneros | Feb 26, 2025 | Buy | $1K – $15K |
| Rob Bresnahan | Feb 25, 2025 | Buy | $15K – $50K |
| Jefferson Shreve | Feb 24, 2025 | Buy | $15K – $50K |
| Julie Johnson | Feb 12, 2025 | Sell | $1K – $15K |
| Gil Cisneros | Jan 24, 2025 | Sell | $1K – $15K |
| Julie Johnson | Jan 15, 2025 | Sell | $1K – $15K |
| Michael Rulli | Nov 26, 2024 | Sell | $1K – $15K |
| Ro Khanna | Nov 13, 2024 | Buy | $1K – $15K |
| Laurel Lee | Oct 21, 2024 | Buy | $15K – $50K |
Frequently Asked Questions: Pfizer Congress Trading
No members of Congress have reported buying or selling PFE stock in the past 90 days. Congressional trades are disclosed under the STOCK Act — view the full history on this page.
Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.
Ro Khanna bought Pfizer (PFE) stock most recently, on July 7, 2026.
The estimated net value of congressional trades in Pfizer over the past 2 years is negative, at -$130,000, meaning members of Congress have on balance sold more than they have bought.
Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.
